Clinical Trial Update: Dose-Finding Study Evaluating Effect on Body Composition of Enobosarm in Patients Taking a GLP-1 for Chronic Weight Mgmt [Phase 2]

View source ↗

Summary

Phase 2 dose-finding trial evaluating enobosarm’s effect on body composition in patients taking a GLP-1 for chronic weight management has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Muscle Wasting
• Obesity

Drugs mentioned

• Enobosarm (enobosarm)

Snippet

Sponsor: Veru Inc. | Conditions: Muscle Loss, Obesity | Phase 2 | Status: COMPLETED